Background and aims: Our studies of the standard neurological examination on 66 middleaged (50-64 yrs) and elderly subjects (65-84 yrs) demonstrate that healthy elders have neurological deficits (or "signs") that are not associated with specific known neurological disease. The purpose of the current study is to describe this loss of neurological function in healthy aging subjects as seen through accumulated subclinical neurological signs present. Methods: Logistic regression is applied to the data on each of six signs. Parameters determined are used to describe the distribution of first occurrence times for each sign. The results are then used to construct a Poisson-like model that describes the accumulation in the number of signs present over time on average. This model is also used to simulate a longitudinal population to explore the variability in the number of signs present over time in an aging population. Results: As the rate of arrival of the signs is heterogeneous, as determined through logistic regression, and the number of signs detected is finite, the resulting distributions of the number of signs over time have a different nature than Poisson. Our results suggest that we can expect to see on average one neurological deficit in healthy people by the age of 62, and that the expected number of deficits increases linearly at the rate of 1 additional sign every 12 years over a wide age range (age 70-90). The distribution of the number of deficits over time is also described. Conclusions: The linearity in the average rate at which signs appear in this population is somewhat of a surprise, in that an increasing (accelerating) rate might be anticipated. In addition to characterizing the neurological exam results in this group, we demon-strate a methodology that allows the comparison of groups and defines a rate of neurological aging. (Aging Clin Exp Res 2008; 20: 368-375) 
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INTRODUCTION
Aging in human populations can be seen as due to accumulations of non-repairable changes. These changes can be identified as resulting from several sources: genetic or mutational events, mechanical (diminished healing capabilities), accidental injury, disease processes, accumulated toxin exposure and the like, and the results of the interactions of the above. In that light, "healthy" aging individuals could be defined as those in whom the aging process progresses without acceleration or delay due to disease, accident, exposure to toxic materials or life choices. There are also temporary changes to the health of an individual that can affect the health status at specific times. All changes, permanent and temporary, are sometimes described as "deficits" in determining the health status of an individual at a particular time.
Characterizing the process of "normal aging" would enable the comparison of groups. For instance, if a population is found to age faster (in some measure) than a general healthy population, there may well be a common external cause, such as disease, exposure to toxic materials, diet, or lack of preventative health care. Such comparisons could also compare groups to detect changes due to long-term prescription or nonprescription drug use or practice (exercise, drinking of green tea, and so on).
Gerontological research, and routine clinical assessments are plagued by the need to decipher those clinical manifestations, which represent "aging," as opposed to "disease" (1). There are questions about the effects of exercise 368 Aging Clin Exp Res, Vol. 20, No. 4
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Aging Clin Exp Res, Vol. 20, No. 4 369 on neural function in the elderly (2, 3), and the relationship between neurological function and falls (4). Previous reports in the literature (5-9) have reported apparent differences in the "usual" features of the aging nervous system (see Table 1 ). These apparent differences may be attributable to differences in accumulated clinical expertise of the testing physician (5), as well as different procedures for subject recruitment in cross-sectional studies (10), differences in how deficits are defined and counted (e.g. decreased vs absent, bilateral vs unilateral) (11, 12) and how long ago studies were performed, reflecting changes in the elderly population over decades (13, 14) . Studies which exclude elderly subjects with any abnormalities by clinical or laboratory testing may bias results towards a description of "ideal" or "optimal" aging, as opposed to "usual" or "average" aging which occurs in the general population.
Previously, we studied a group of subjects who were active and generally in good health, with no reported specific neurological disease, to see which changes could be found on clinical and laboratory testing using a cross-sectional study design (15) (16) (17) (18) . Our study of the neurological examination of healthy adults, ages 53-84 years, demonstrates considerable heterogeneity in the population, even among subjects of similar ages. That is, not all subjects of a specific age have exactly the same neurological deficits. Despite these differences, we identified a general trend of losses in neurological function from middle age to the elderly. Our data from the neurological examination is described by a Poisson-like model that defines the age at which the neurological exam begins to change in middle-aged adults, the changes that tend to occur first, and the age by which we can expect to see these neurological changes in every person, even those in good general health. Counting the number of random events that have occurred by age a in individuals is a common problem in insurance and medicine. If the rate at which the events "arrive" remains constant over time, the result is a Poisson Process. In this case, at each age, the number of in- 
